Literature DB >> 14690597

The structure of the APPBP1-UBA3-NEDD8-ATP complex reveals the basis for selective ubiquitin-like protein activation by an E1.

Helen Walden1, Michael S Podgorski, Danny T Huang, David W Miller, Rebecca J Howard, Daniel L Minor, James M Holton, Brenda A Schulman.   

Abstract

E1 enzymes initiate ubiquitin-like protein (ubl) transfer cascades by catalyzing adenylation of the ubl's C terminus. An E1's selectivity for its cognate ubl is essential because the E1 subsequently coordinates the ubl with its correct downstream pathway. We report here the structure of the 120 kDa quaternary complex between human APPBP1-UBA3, a heterodimeric E1, its ubl NEDD8, and ATP. The E1 selectively recruits NEDD8 through a bipartite interface, involving a domain common to all ubl activating enzymes including bacterial ancestors, and also eukaryotic E1-specific sequences. By modeling ubiquitin into the NEDD8 binding site and performing mutational analysis, we identify a single conserved arginine in APPBP1-UBA3 that acts as a selectivity gate, preventing misactivation of ubiquitin by NEDD8's E1. NEDD8 residues that interact with E1 correspond to residues in ubiquitin important for binding the proteasome and other ubiquitin-interacting proteins, suggesting that the conjugation and recognition machineries have coevolved for each specific ubl.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14690597     DOI: 10.1016/s1097-2765(03)00452-0

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  104 in total

1.  A unique E1-E2 interaction required for optimal conjugation of the ubiquitin-like protein NEDD8.

Authors:  Danny T Huang; David W Miller; Rose Mathew; Robert Cassell; James M Holton; Martine F Roussel; Brenda A Schulman
Journal:  Nat Struct Mol Biol       Date:  2004-09-07       Impact factor: 15.369

Review 2.  Getting into position: the catalytic mechanisms of protein ubiquitylation.

Authors:  Lori A Passmore; David Barford
Journal:  Biochem J       Date:  2004-05-01       Impact factor: 3.857

Review 3.  Twists and turns in ubiquitin-like protein conjugation cascades.

Authors:  Brenda A Schulman
Journal:  Protein Sci       Date:  2011-11-09       Impact factor: 6.725

4.  Small ubiquitin-like modifier (SUMO) modification of E1 Cys domain inhibits E1 Cys domain enzymatic activity.

Authors:  Khue Truong; Terry D Lee; Yuan Chen
Journal:  J Biol Chem       Date:  2012-03-08       Impact factor: 5.157

5.  Mechanistic studies of substrate-assisted inhibition of ubiquitin-activating enzyme by adenosine sulfamate analogues.

Authors:  Jesse J Chen; Christopher A Tsu; James M Gavin; Michael A Milhollen; Frank J Bruzzese; William D Mallender; Michael D Sintchak; Nancy J Bump; Xiaofeng Yang; Jingya Ma; Huay-Keng Loke; Qing Xu; Ping Li; Neil F Bence; James E Brownell; Lawrence R Dick
Journal:  J Biol Chem       Date:  2011-10-03       Impact factor: 5.157

6.  Mechanism of E1-E2 interaction for the inhibition of Ubl adenylation.

Authors:  Jianghai Wang; Sheng Cai; Yuan Chen
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

7.  Role of the Zn(2+) motif of E1 in SUMO adenylation.

Authors:  Jianghai Wang; Yuan Chen
Journal:  J Biol Chem       Date:  2010-05-25       Impact factor: 5.157

Review 8.  Inhibition of NEDD8-conjugation pathway by novel molecules: potential approaches to anticancer therapy.

Authors:  Tomoaki Tanaka; Tatsuya Nakatani; Tetsu Kamitani
Journal:  Mol Oncol       Date:  2012-01-21       Impact factor: 6.603

9.  Structures of the SUMO E1 provide mechanistic insights into SUMO activation and E2 recruitment to E1.

Authors:  Luisa Maria Lois; Christopher D Lima
Journal:  EMBO J       Date:  2005-01-20       Impact factor: 11.598

10.  Crystal structure of a human ubiquitin E1-ubiquitin complex reveals conserved functional elements essential for activity.

Authors:  Zongyang Lv; Katelyn M Williams; Lingmin Yuan; James H Atkison; Shaun K Olsen
Journal:  J Biol Chem       Date:  2018-10-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.